Risks and Benefits of Antiplatelet Therapy in Uremic Patients

被引：12
作者：
Washam, Jeffrey B.
Adams, George L. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Duke Heart Ctr, Durham, NC 27710 USA
来源：
ADVANCES IN CHRONIC KIDNEY DISEASE | 2008年 / 15卷 / 04期
关键词：
Uremia; Antiplatelet therapy; Acute coronary syndrome;
D O I：
10.1053/j.ackd.2008.07.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with renal insufficiency are at an increased risk for cardiovascular morbidity and mortality. Despite being at a substantial risk for thrombotic events, patients with renal insufficiency also experience a greater number of hemorrhagic complications associated with antiplatelet therapy than individuals with normal renal function. This review focuses on the benefits and risks of antiplatelet therapy in patients with impaired kidney function suffering from an acute coronary syndrome. (C) 2008 by the National Kidney Foundation, Inc. All rights reserved
引用
收藏
页码：370 / 377
页数：8
相关论文
共 50 条
  • [31] Perioperative discontinuation of antiplatelet therapy of patients with coronary stents
    Graw, J.
    Schwenk, W.
    Volk, T.
    CHIRURG, 2009, 80 (06): : 498 - 501
  • [32] Antiplatelet therapy alters iron requirements in hemodialysis patients
    Goicoechea, M
    Caramelo, C
    Ochando, A
    Andrea, C
    Garvía, R
    Ortiz, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) : 80 - 87
  • [33] Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
    Muhlestein, Joseph B.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (01) : 71 - 82
  • [34] Antiplatelet therapy for elderly patients with Acute Coronary Syndromes
    Savonitto, Stefano
    Morici, Nuccia
    De Servi, Stefano
    AGING-US, 2018, 10 (09): : 2220 - 2221
  • [35] Antiplatelet Therapy in Acute Coronary Syndromes
    Aragam, Krishna G.
    Bhatt, Deepak L.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 16 (01) : 24 - 42
  • [36] Antiplatelet therapy in acute coronary syndromes
    Barker C.M.
    Price M.J.
    Current Cardiology Reports, 2008, 10 (4) : 327 - 333
  • [37] Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention
    Foo, Fiona
    Oldroyd, Keith G.
    BIOMARKERS IN MEDICINE, 2011, 5 (01) : 9 - 30
  • [38] Practical Aspects of Monitoring of Antiplatelet Therapy
    Jovanovic, Ljubica
    Antonijevic, Nebojsa
    Novakovic, Tina
    Savic, Nebojsa
    Terzic, Branka
    Zivkovic, Ivana
    Radovanovic, Nebojsa
    Asanin, Milika
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (01) : 14 - 23
  • [39] Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy
    Cryer, Byron
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 289 - +
  • [40] Benefits and limitations of current antiplatelet therapies
    Nappi, Jean
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (13) : S5 - S10
12345